Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2003
10/09/2003WO2003082820A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082334A1 Drugs for increasing lacrimal fluid
10/09/2003WO2003082315A1 Remedy for hypermyotonia
10/09/2003WO2003082313A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003WO2003082293A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082285A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082274A1 Angiogenesis inhibitors
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082257A2 Method for treating ocular hypertension and glaucoma
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082081A2 Use of rom production and release inhibitors to treat and prevent intraocular damage
10/09/2003WO2003045917A3 Ccr-3 receptor antagonists vii
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003WO2002034246A3 Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
10/09/2003WO2002016434A9 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191285 Novel g protein-coupled receptor proteins and dnas thereof
10/09/2003US20030191181 4-[(8-Ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome P450RAI inhibitory activity
10/09/2003US20030191180 Pharmaceutical compositions
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191175 Indole sPLA2 inhibitors
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191092 MMP inhibitors
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191072 Gene therapy for proliferative vitreoretinopathy
10/09/2003US20030190642 Thymus expressed human cytochrome p450(p450tec)
10/09/2003US20030190368 Identification of cellular activation factors and their use as diagnostic markers
10/09/2003US20030190363 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
10/09/2003US20030190328 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2480047A1 Use of rom production and release inhibitors to treat and prevent intraocular damage
10/09/2003CA2479915A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2479912A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477751A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1350512A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349580A1 Process to improve stability of a pharmaceutical composition
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447688A Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
10/08/2003CN1446582A Preparation for eyes
10/08/2003CN1123350C Medicine for treating oyeground affection of diabetes
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630497 For therapy of hypertension and congestive heart failure; angiotensin II antagonist
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630473 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630157 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
10/07/2003US6630128 Insoluble support
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080659A1 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
10/02/2003WO2003080648A2 Raav vector compositions and methods for the treatment of choroidal neovascularization
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080096A1 Compositions for treating and/or preventing pollenosis
10/02/2003WO2003080091A1 Herbal ophthalmic formulation for preventing cataract
10/02/2003WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 531